Respiratory Physician & Co-CD Respiratory Clinical Network NHSE (London). Passionate about care delivery that benefits the population, condition and individual.
@anish_k_patel @DrEmmaNash This is extraordinary.Can I ask who wrote this pathway?patients with COPD can be breathless for many reasons and should be supported by a respiratory community team (or GP )with a personalised care plan and support number to contact if deteriorates.
🆕 - our paper to design and implement a tool to guide inhaler selection at the point of discharge for hospitalised exacerbation of #COPD has now been published in @ERSpublications ERJ Open Research.
👀👇🏻
https://t.co/afhYHrzsgn
The most wonderful thing about conferences, alongside cutting edge & practice changing science, is the opportunity to catch up with friends & mentors
Team Resp really is the absolute best
💙🫁💙🫁💙🫁💙
#RespIsBest#WomenInSTEM#BTSWinter2023#WomenInMedicine#WomenInScience
COPD is massively overdiagnosed in people with bronchiectasis - many patients have the label and have no airflow obstruction or have never smoked
Almost half of COPD diagnoses do not meet objective criteria in nearly 1700 European patients in EMBARC
@EvaPolverino#ERSCongress
In patients with moderate to very severe COPD and a history of exacerbation, 1 year treatment with doxycycline does not reduce exacerbation rate compared to placebo. However, patients with FEV1<50% or low blood eosinophils may benefit https://t.co/ahbRkns1gw @ATSBlueEditor
Better treatment and care for lung conditions like COPD starts with an accurate and timely diagnosis. Great article from @pulsetoday below which highlights the lack of spirometry testing in England, ahead of @asthmalunguk's upcoming report.
We're now playing a video of our 'virtual wards' – a development that illustrates the NHS's renewed impetus, accelerated by the pandemic, for working more collaboratively to provide better care, for more patients, more efficiently.
Watch this video: https://t.co/gqbHMNf3yW
Our new report #BreathingUnequal has revealed that nearly half of the lowest earners surveyed said they couldn’t afford to pay for prescriptions.
The cost of living is doing irreparable damage to people with lung conditions. We are calling on the Government to take action now.